Cita APA (7a ed.)

Kato, T., Ono, H., Fujii, M., Akahoshi, K., Ogura, T., Ogawa, K., . . . Tanabe, M. (2021). Cytoplasmic RRM1 activation as an acute response to gemcitabine treatment is involved in drug resistance of pancreatic cancer cells. Public Library of Science (PLoS).

Cita Chicago Style (17a ed.)

Kato, Tomotaka, et al. Cytoplasmic RRM1 Activation as an Acute Response to Gemcitabine Treatment Is Involved in Drug Resistance of Pancreatic Cancer Cells. Public Library of Science (PLoS), 2021.

Cita MLA (8a ed.)

Kato, Tomotaka, et al. Cytoplasmic RRM1 Activation as an Acute Response to Gemcitabine Treatment Is Involved in Drug Resistance of Pancreatic Cancer Cells. Public Library of Science (PLoS), 2021.